ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1126

Synovial Cell Dysfunction in Obese Patients May Contribute to Poor Outcomes in Knee Osteoarthritis

Holly Philpott1, Trevor Birmingham2, Nicole Aye2, Benoit Fiset3, Logan Walsh3, Brent Lanting2 and Tom Appleton2, 1Western University, London, ON, Canada, 2University of Western Ontario, London, ON, Canada, 3McGill University, Montréal, QC, Canada

Meeting: ACR Convergence 2021

Keywords: Inflammation, obesity, Osteoarthritis, RNA sequencing

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Title: Osteoarthritis – Clinical Poster III (1118–1134)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Obesity is a major risk factor for poor outcomes in knee osteoarthritis (OA) and may involve both mechanical and physiological stresses on joint tissues. In the synovium, macrophages and fibroblasts are important for maintaining joint homeostasis and adaptive responses to joint stressors. However, the impact of obesity on synovial cellular mechanisms are not well understood. Our objectives were 1) to investigate the association of obesity and synovial histopathological features, and 2) to explore the effect of obesity on synovial cell gene expression in people with knee OA.

Methods: Patients (n=107) diagnosed with clinical knee OA based on the American College of Rheumatology (ACR) criteria were included in this cross-sectional analysis. All patients had severe symptoms and radiographic damage (KL grade 3 or 4), and were undergoing surgery for knee OA. Lateral suprapatellar synovial tissue biopsies were obtained during surgery. Routine synovial histopathology was scored (grade 0-3; None-Severe) in six domains. Multivariate linear regression was used to evaluate the association between median histopathology component scores and BMI, while adjusting for age and sex. Single cells dissociated from whole synovium biopsies were sorted into CD14+ (macrophage/monocyte) and CD90+ (stromal) cell compartments for RNA isolation and sequencing. Quantification of genes was performed in featureCounts and DESeq2 was used to normalize counts. Gene set enrichment was assessed using mSigDB Hallmark gene sets between patients with BMI < 30kg/m2 (n=7) and BMI >35kg/m2 (n=6).

Results: Elevated BMI was associated with lower median synovial vascularization (β = -1.35, [95%CI -2.43, -0.27]) and fibrin deposition (β = -3.80, [95%CI -6.98, -0.62]) histopathology scores. In normal to overweight patients (BMI < 30kg/m2 ), CD14+ macrophage gene expression showed significant enrichment scores for immune cell signaling (e.g. TNF-α signaling, IFN-γ and IFN-α response, IL6/JAK/STAT3 signaling) and cell metabolism pathways (e.g. fatty acid metabolism, adipogenesis, oxidative phosphorylation, mTOR signaling). CD90+ stromal cell gene expression also showed significant enrichment scores for response to pro-inflammatory signaling pathways and cell metabolism pathways. In obese patients (BMI >35kg/m2), synovial macrophage and stromal cell compartments both showed enrichment of cell stress and degenerative pathways (e.g. p53 pathway, unfolded protein response, apoptosis, hypoxia, epithelial-mesenchymal transition, hedgehog signaling, Wnt/β-catenin signaling, TGF-β signaling).

Conclusion: Obesity was associated with reduced signs of inflammation in synovial tissues (vascularization and fibrin), and with less inflammatory signaling, impaired cellular metabolism, and greater cellular stress in synovial macrophages and stromal cells. Our results suggest synovial inflammation and vascularization may be adaptive responses to OA-related joint stresses, and that obesity may impair these adaptive synovial processes.


Disclosures: H. Philpott, None; T. Birmingham, None; N. Aye, None; B. Fiset, None; L. Walsh, None; B. Lanting, Stryker, 2, 5, DePuy, 2, 5, Smith & Nephew, 2, 5, Zimmer, 2, 5; T. Appleton, Abbvie, 2, Amgen, 2, Bristol Myers Squibb, 2, Celgene, 2, Fresenius Kabi, 2, Gilead, 2, Janssen, 2, Merck, 2, Novartis, 2, Pfizer, 2, Hoffman LaRoche, 2, Sandoz, 2, Sanofi-Genzyme, 2, UCB, 2.

To cite this abstract in AMA style:

Philpott H, Birmingham T, Aye N, Fiset B, Walsh L, Lanting B, Appleton T. Synovial Cell Dysfunction in Obese Patients May Contribute to Poor Outcomes in Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/synovial-cell-dysfunction-in-obese-patients-may-contribute-to-poor-outcomes-in-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-cell-dysfunction-in-obese-patients-may-contribute-to-poor-outcomes-in-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology